Clinical Trial Update: Hemocoagulation and Lipoperoxidation in Women Using Combined Oral Contraceptives, Correction by Antioxidants [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating coagulation and lipoperoxidation in women using combined oral contraceptives, with potential correction by antioxidants, in polycystic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperandrogenism
• Menstrual Irregularities
• Polycystic Ovary Syndrome

Drugs mentioned

• Combined oral contraceptives
• antioxidants

Snippet

Sponsor: Tyumen State Medical Academy | Conditions: Polycystic Ovarian Syndrome, Hyperandrogenism | Phase 4 | Status: UNKNOWN